Eurolyser Diagnostica enhances the test portfolio for the smart point of care center. As of January 2009, D-Dimer and Haemoglobin tests will be added to the existing test which include CRP, hsCRP, Lipoprotein(a), Microalbumin and Homocystein. This portfolio makes the Eurolyser smart the most flexible, multi use point of care instrument in the market. A great investment for practitioners as well as laboratories – and a great benefit for patients.

Eurolyser Diagnostica constantly enhances the test portfolio for the smart point of care platform and plans to add 2-3 new test per year.